Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) in patients two years of age and older.¹ Post hoc analysis of patients with LGS, transitioning from the randomized...
Covered in this story
What has happened since
- Associated Bancorp is down 7.7% since this was published, 76 days ago.
- Lennox International is down 18.6% since this was published, 76 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ASB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Associated Bancorp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.